Rhinovirus Genotypes Circulating in Bulgaria, 2018-2021.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
22 07 2023
Historique:
received: 27 06 2023
revised: 19 07 2023
accepted: 20 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Rhinoviruses (RV) are one of the most common causative agents of respiratory infections, with significant socioeconomic impact. RV infections are not notifiable in Bulgaria, and little is known about the different RV genotypes circulating in the country. This study aims to investigate the diversity of RV genotypes that were circulating in Bulgaria in the period 2018-2021 in samples from ILI/ARI patients. Genotype assignment was based on sequencing and phylogenetic analysis of the 5' untranslated region and the VP4-VP2 region. Out of a total of 1385 nasopharyngeal swabs tested, 166 were RV-positive (RV detection rate: 11.99% (166/1385)). Those with a cycle threshold <25 were selected for genotyping (n = 63). RV isolates were successfully genotyped and classified into 34 genotypes within

Identifiants

pubmed: 37515294
pii: v15071608
doi: 10.3390/v15071608
pmc: PMC10385483
pii:
doi:

Substances chimiques

5' Untranslated Regions 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Mol Evol. 1980 Dec;16(2):111-20
pubmed: 7463489
J Clin Microbiol. 2009 Dec;47(12):3958-67
pubmed: 19828751
J Clin Virol. 2011 Jun;51(2):121-5
pubmed: 21514213
J Gen Virol. 2010 Oct;91(Pt 10):2409-19
pubmed: 20610666
J Clin Microbiol. 2008 Feb;46(2):533-9
pubmed: 18057136
J Clin Microbiol. 1998 Feb;36(2):539-42
pubmed: 9466772
Methods Mol Biol. 2015;1221:39-47
pubmed: 25261305
J Gen Virol. 2013 Aug;94(Pt 8):1791-1806
pubmed: 23677786
Arch Intern Med. 2003 Feb 24;163(4):487-94
pubmed: 12588210
J Clin Virol. 2018 Apr;101:11-17
pubmed: 29414181
J Virol. 2010 Oct;84(19):10297-310
pubmed: 20668080
Evolution. 1985 Jul;39(4):783-791
pubmed: 28561359
Science. 2009 Apr 3;324(5923):55-9
pubmed: 19213880
J Allergy Clin Immunol. 2013 Jan;131(1):69-77.e1-6
pubmed: 23146382
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Arch Virol. 2015 Jul;160(7):1837-50
pubmed: 25913692
PLoS One. 2007 Oct 03;2(10):e966
pubmed: 17912345
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
J Clin Virol. 2009 Sep;46(1):85-9
pubmed: 19581125
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
J Clin Microbiol. 2008 Nov;46(11):3736-45
pubmed: 18753359
Rev Med Virol. 2004 Jan-Feb;14(1):17-31
pubmed: 14716689
J Clin Microbiol. 2014 Jul;52(7):2461-71
pubmed: 24789198
Eur Respir J. 2011 May;37(5):1037-42
pubmed: 20693244
Influenza Other Respir Viruses. 2016 Nov;10(6):493-503
pubmed: 27383422
J Infect Dis. 2006 Nov 15;194(10):1398-402
pubmed: 17054069

Auteurs

Irina Georgieva (I)

Department of Virology, National Centre of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.

Asya Stoyanova (A)

Department of Virology, National Centre of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.

Svetla Angelova (S)

Clinic of Infectious Diseases, University Hospital "Prof. Dr. Stoyan Kirkovich" AD, 6003 Stara Zagora, Bulgaria.

Neli Korsun (N)

Department of Virology, National Centre of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.

Savina Stoitsova (S)

Department of Virology, National Centre of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.

Lubomira Nikolaeva-Glomb (L)

Department of Virology, National Centre of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH